Combined Use of Clofibrate and Cholestyramine or DEAE Sephadex in Hypercholesterolaemia
- 3 July 1971
- Vol. 3 (5765), 25-27
- https://doi.org/10.1136/bmj.3.5765.25
Abstract
A comparison was made of the effect of DEAE (diethylaminoethyl) Sephadex (an anion exchange resin) and cholestyramine (Questran) with and without the addition of clofibrate in normal and hypercholesterolaemic patients. DEAE Sephadex (12-15 g/day) alone appeared to be as effective as cholestyramine in lowering the plasma cholesterol by 12-15%. Clofibrate acted synergistically with DEAE Sephadex and increased the activity of the latter by over twofold. This combination proved superior to that of clofibrate and cholestyramine and has the greatest potential use in the treatment of type II pattern hyperlipoproteinaemia.Keywords
This publication has 6 references indexed in Scilit:
- Turnover of plasma cholesterol in manJournal of Clinical Investigation, 1968
- Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and DisordersNew England Journal of Medicine, 1967
- Hypolipidemic effects of orally administered dextran and cellulose anion exchangers in cockerels and dogsJournal of Lipid Research, 1967
- Cholestyramine Resin Therapy for HypercholesteremiaJAMA, 1965
- A semiautomated procedure for the determination of triglycerides in serumAnalytical Biochemistry, 1964
- A REVISION OF THE SCHOENHEIMER-SPERRY METHOD FOR CHOLESTEROL DETERMINATIONJournal of Biological Chemistry, 1950